NASDAQ:INNT - Innovate Biopharmaceuticals Stock Price, Forecast & News

Innovate Biopharmaceuticals trades on the NASDAQ under the ticker symbol "INNT."

Innovate Biopharmaceuticals Inc (NASDAQ:INNT) announced its earnings results on Thursday, November, 7th. The company reported ($0.19) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.14) by $0.05. View Innovate Biopharmaceuticals' Earnings History.

Innovate Biopharmaceuticals is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Innovate Biopharmaceuticals.

1 brokers have issued 1-year price targets for Innovate Biopharmaceuticals' stock. Their forecasts range from $10.00 to $10.00. On average, they expect Innovate Biopharmaceuticals' share price to reach $10.00 in the next year. This suggests a possible upside of 1,101.2% from the stock's current price. View Analyst Price Targets for Innovate Biopharmaceuticals.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innovate Biopharmaceuticals in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Innovate Biopharmaceuticals.

Headlines about INNT stock have been trending extremely negative this week, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Innovate Biopharmaceuticals earned a daily sentiment score of -4.5 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the near term. View News Stories for Innovate Biopharmaceuticals.

Innovate Biopharmaceuticals saw a increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,830,000 shares, an increase of 8.9% from the December 15th total of 1,680,000 shares. Based on an average daily volume of 431,300 shares, the short-interest ratio is presently 4.2 days. Approximately 8.0% of the company's stock are sold short. View Innovate Biopharmaceuticals' Current Options Chain.

Some companies that are related to Innovate Biopharmaceuticals include CymaBay Therapeutics (CBAY), REDHILL BIOPHAR/S (RDHL), Zynerba Pharmaceuticals (ZYNE), ProMetic Life Sciences (PFSCF), Northwest Biotherapeutics (NWBO), Sierra Oncology (SRRA), Clearside Biomedical (CLSD), Chimerix (CMRX), Gemphire Therapeutics (GEMP), Galmed Pharmaceuticals (GLMD), Marinus Pharmaceuticals (MRNS), Paratek Pharmaceuticals (PRTK), ESSA Pharma (EPIX), Aduro BioTech (ADRO) and Trillium Therapeutics (TRIL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Innovate Biopharmaceuticals investors own include NIO (NIO), Corbus Pharmaceuticals (CRBP), Axsome Therapeutics (AXSM), AcelRx Pharmaceuticals (ACRX), Iterum Therapeutics (ITRM), Momo (MOMO), Alibaba Group (BABA), Inovio Pharmaceuticals (INO), Progenics Pharmaceuticals (PGNX) and Sorrento Therapeutics (SRNE).

Shares of INNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of INNT stock can currently be purchased for approximately $0.83.

Innovate Biopharmaceuticals has a market capitalization of $29.87 million. The company earns $-24,160,000.00 in net income (profit) each year or ($0.98) on an earnings per share basis. Innovate Biopharmaceuticals employs 8 workers across the globe.View Additional Information About Innovate Biopharmaceuticals.

The official website for Innovate Biopharmaceuticals is http://www.innovatebiopharma.com/.

Innovate Biopharmaceuticals' mailing address is 8480 HONEYCUTT ROAD SUITE 120, RALEIGH NC, 27615. The company can be reached via phone at 919-275-1933 or via email at [email protected]